Intellia Therapeutics, Inc. (NTLA): 10-Q filed May 11, 2026

Form type

10-Q

Filing date

May 11, 2026

Accession number

0001193125-26-215740

Filer

Intellia Therapeutics, Inc. (CIK 1652130)